Reported Reactions

Devices › Device types

FDA product code LNS · class 2 · Gastroenterology, Urology

Lithotriptor, extracorporeal shock-wave, urological: medical device reports filed with FDA

815 reports carry this product code, 1993–2026; 2 brands with a page.

815
reports with this product code
0% of all MAUDE reports
33
reports, 12 months to August 2026
57 in the 12 months before
21%
classified as malfunction
62.3% across all reports
3.7%
classified as death, as reported
0.9% across all reports

Product code LNS is FDA's classification for "Lithotriptor, extracorporeal shock-wave, urological" (gastroenterology, Urology panel), a class 2 device. 815 medical device reports carry this product code, 0% of the MAUDE database, from August 1993 to August 2026.

33 reports arrived in the 12 months to August 2026, down 42% from 57 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (70.3%), malfunction (21%) and other (3.9%). 2 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

BrandReportsLatest 12 monthsClassified as deathClassified as malfunction
Dornier Holmium Laser Fiber100%98.9%
Enterra100.8%32.3%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)ReportsShare
Reynosa Manufacturing30.4%
Mdt Puerto Rico Operations Juncos10.1%
Siemens Medical Solutions USA10.1%
Varian Medical Systems10.1%

Reports by month, five years

01223Sep 2021: 5Oct 2021: 3Nov 2021: 1Dec 2021: 42022Jan 2022: 3Feb 2022: 4Mar 2022: 3Apr 2022: 6May 2022: 8Jun 2022: 3Jul 2022: 3Aug 2022: 5Sep 2022: 7Oct 2022: 1Nov 2022: 8Dec 2022: 12023Jan 2023: 3Feb 2023: 1Mar 2023: 6Apr 2023: 5May 2023: 23Jun 2023: 11Jul 2023: 7Aug 2023: 7Sep 2023: 6Oct 2023: 5Nov 2023: 0Dec 2023: 122024Jan 2024: 7Feb 2024: 4Mar 2024: 2Apr 2024: 3May 2024: 3Jun 2024: 5Jul 2024: 3Aug 2024: 4Sep 2024: 2Oct 2024: 2Nov 2024: 2Dec 2024: 32025Jan 2025: 9Feb 2025: 4Mar 2025: 2Apr 2025: 4May 2025: 6Jun 2025: 8Jul 2025: 11Aug 2025: 4Sep 2025: 4Oct 2025: 4Nov 2025: 3Dec 2025: 22026Jan 2026: 2Feb 2026: 4Mar 2026: 3Apr 2026: 2May 2026: 1Jun 2026: 4Jul 2026: 0Aug 2026: 4

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death3.7%30
Injury70.3%573
Malfunction21%171
Other3.9%32
Not given1.1%9

Who filed

Manufacturer report56%456
Voluntary report3.7%30
User facility report0%0
Distributor report35.6%290
Not given4.8%39

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)ReportsShare
Device displays incorrect message242.9%
Device operates differently than expectedthe device behaved unexpectedly212.6%
Insufficient device problem information212.6%
Normal141.7%
Device inoperablethe device could not be used111.3%
Loss of powerthe device lost power81%
Device issuea problem with the device70.9%
Defibrillation/stimulation problem60.7%
Fluid/blood leak60.7%
Improper or incorrect procedure or method60.7%
Failure to power up50.6%
Repair50.6%
Failure to fire40.5%
Noise, audible40.5%
Therapeutic or diagnostic output failure40.5%
Abnormal30.4%
Breakthe device broke30.4%
Computer operating system problem30.4%
Defective component30.4%
Detachment of device component30.4%

Questions about lithotriptor, extracorporeal shock-wave, urological reports

What is product code LNS?

FDA's classification code for "Lithotriptor, extracorporeal shock-wave, urological", class 2, reviewed by the gastroenterology, Urology panel. Every device report carries the product code of the device involved.

How many reports carry this code?

815 reports through August 2026, 33 of them in the latest 12 months.

Which brands appear most often?

Dornier Holmium Laser Fiber (1) and Enterra (1). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.